Viridian Therapeutics Inc VRDN Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Viridian Therapeutics Inc (VRDN)
Viridian Therapeutics Inc (VRDN) Financials

Viridian Therapeutics Inc (VRDN)

19.45

-0.38

(-1.92%)

Closed 29 December 8:00AM

Delayed by 15 minutes

19.45

0.00

(0.00%)

After Hours: 10:56AM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-147.707	-93.451	-55.135	-86.865	-137.094	-47.416	-40.662	-51.373
Return on Equity (%)	-251.369	-138.864	-72.791	-124.811	491.957	-125.107	-44.571	-56.8
Return on Invested Capital (%)	-232.615	-110.421	-61.449	-105.767	-158.521	-52.211	-45.92	-59.15
Operating Margin (%)	-376.955	-652.735	-379.561	-919.928	-10495.905	-2680.054	-7301.806	-75123.248
Net Profit Margin (%)	-379.802	-662.303	-389.971	-938.646	-10544.286	-2680.155	-7329.233	-75711.465
Book Value Per Share	-0.439	1.706	1.665	0.452	28.371	2.252	6.123	4.452
Earnings Per Share	-17.081	-1.175	-1.06	-1.201	-26.168	-3.319	-3.144	-4.494
Cash Per Share	4.503	2.102	1.057	0.713	10.848	1.768	3.766	1.944
Working Capital Per Share	-0.439	2.126	1.901	0.561	28.111	7.797	9.631	8.692
Operating Profit Per Share	1.318	0.177	0.272	0.128	0.248	0.124	0.043	0.006
EBIT Per Share	-17.081	-1.175	-1.06	-1.201	-26.168	-3.319	-3.144	-4.494
EBITDA Per Share	-17.081	-1.175	-1.06	-1.201	-26.168	-3.319	-3.144	-4.494
Free Cash Flow Per Share	-17.332	-1.178	-1.055	-1.207	-26.214	-3.31	-3.131	-4.487

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	742k	22.57M	30.84M	34.86M	4.23M	23.92M	41.31M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	41.31M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-69373.469	N/A	N/A	N/A	-66604.167	N/A	N/A
Net Profit Margin (%)	N/A	-69541.837	N/A	N/A	N/A	-67419.444	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	1.57B
Price to Earnings Ratio	-6.48
Price to Sales Ratio	4.86k
Price to Cash Ratio	14.98
Price to Book Ratio	3.49
Dividend Yield	-

Share Statistics

Shares Outstanding	79.21M
Average Volume (1 week)	1.78M
Average Volume (1 Month)	1.74M
52 Week Change	-14.32%
52 Week High	27.20
52 Week Low	11.40

More Ratios Coming Soon!

Viridian Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions